J D Karkas

1.3k citations

21 papers · 1.1k indexed · h-index 14

Co-authors: Erwin Chargaff Rivka Rudner Richard L. Tolman Richard Liou John I. Germershausen Anjalie Field Wallace T. Ashton Helen C. Perry
Topics: Herpesvirus Infections and Treatments (6 papers)Cytomegalovirus and herpesvirus research (6 papers)Metal complexes synthesis and properties (3 papers)
Cited by: Epidemiology Molecular Biology Biotechnology
Journals: Proceedings of the National Academy of Sciences Journal of Biological Chemistry Biochemical and Biophysical Research Communications
Partner nations: United States Canada Australia

In The Last Decade

J D Karkas

21 papers receiving 985 citations

Peers

Countries citing papers authored by J D Karkas

Since Specialization

Citations

This map shows the geographic impact of J D Karkas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J D Karkas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J D Karkas more than expected).

Fields of papers citing papers by J D Karkas

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J D Karkas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J D Karkas. The network helps show where J D Karkas may publish in the future.

Co-authorship network of co-authors of J D Karkas

This figure shows the co-authorship network connecting the top 25 collaborators of J D Karkas. A scholar is included among the top collaborators of J D Karkas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J D Karkas. J D Karkas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Evaluation of retinal toxicity and liposome encapsulation of the anti-CMV drug 2'-nor-cyclic GMP. 1993 ·PubMed ·(unknown),Kerry K. Assil,(unknown),(unknown),Marisa Flores-Aguilar,(unknown),Clayton A. Wiley,Richard L. Tolman,J D Karkas,(unknown)	13
2	Zaragozic acids: a family of fungal metabolites that are picomolar competitive inhibitors of squalene synthase. 1993 ·Proceedings of the National Academy of Sciences ·James D. Bergstrom,Marc M. Kurtz,Deborah J. Rew,(unknown),J D Karkas,R. Bostedor,Vinay S. Bansal,C. DUFRESNE,Frank VanMiddlesworth,Otto D. Hensens	285
3	Assessment of a selective inhibitor of herpes simplex virus thymidine kinase (L-653,180) as therapy for experimental recurrent genital herpes 1992 ·Antimicrobial Agents and Chemotherapy ·Nigel Bourne,Fernando Bravo,Wallace T. Ashton,Laura C. Meurer,Richard L. Tolman,J D Karkas,Lawrence R. Stanberry	14
4	Lowering of plasma cholesterol levels in animals by lovastatin and simvastatin 1991 ·European Journal of Clinical Pharmacology ·Y S Chao,(unknown),V. M. Hunt,G. W. Kuron,J D Karkas,Richard Liou,Alfred W. Alberts	15
5	Lowering of plasma cholesterol levels in animals by lovastatin and simvastatin 1991 ·European Journal of Clinical Pharmacology ·Y S Chao,(unknown),V. M. Hunt,G. W. Kuron,J D Karkas,Richard Liou,Alfred W. Alberts	23
6	Suppression of herpes simplex virus type 1 reactivation from latency by (+-)-9-([(Z)-2-(hydroxymethyl)cyclohexyl]methyl) guanine (L-653,180) in vitro 1990 ·Antimicrobial Agents and Chemotherapy ·(unknown),Richard L. Tolman,J D Karkas,Fred Rapp	10
7	ChemInform Abstract: Synthesis and Antiherpetic Activity of (.+‐.)‐9‐((Z‐2‐(Hydroxymethyl)cyclopropyl)methyl)guanine and Related Compounds. 1989 ·ChemInform ·Wallace T. Ashton,Laura C. Meurer,(unknown),Anjalie Field,John Hannah,J D Karkas,Richard Liou,Gool F. Patel,Helen C. Perry,Arthur F. Wagner,Edward Walton,Richard L. Tolman	3
8	A Potent, Selective, Non-Substrate Inhibitor of HSV-I Thymidine Kinase: (±)-9-[[(Z)-2-(Hydroxymethyl)Cyclohexyl]Methyl]Guanine and Related Compounds 1989 ·Nucleosides Nucleotides & Nucleic Acids ·Wallace T. Ashton,Laura C. Meurer,Richard L. Tolman,J D Karkas,Richard Liou,(unknown),(unknown),Richard J. Klein	15
9	ChemInform Abstract: Synthetic, Biochemical and Antiviral Aspects of Selected Acyclonucleosides and Their Derivatives. 1986 ·Chemischer Informationsdienst ·Malcolm MacCoss,(unknown),Wallace T. Ashton,Arthur F. Wagner,John Hannah,Anjalie Field,J D Karkas,John I. Germershausen	7
10	Enzymatic phosphorylation of the antiherpetic agent 9-[(2,3-dihydroxy-1-propoxy)methyl]guanine 1986 ·Journal of Medicinal Chemistry ·J D Karkas,Wallace T. Ashton,(unknown),Richard Liou,John I. Germershausen,R. Bostedor,Byron Arison,Anjalie Field,Richard L. Tolman	14
11	2′-nor-cGMP: A seco-cyclic nucleotide with powerful anti-DNA-viral activity 1985 ·Biochemical and Biophysical Research Communications ·Richard L. Tolman,Anjalie Field,J D Karkas,Arthur F. Wagner,John I. Germershausen,Clyde S. Crumpacker,E M Scolnick	41
12	9-([2-hydroxy-1-(hydroxymethyl)ethoxy]methyl)guanine: a selective inhibitor of herpes group virus replication. 1983 ·Proceedings of the National Academy of Sciences ·Anjalie Field,M E Davies,Corrille M. DeWitt,Helen C. Perry,Richard Liou,John I. Germershausen,J D Karkas,Wallace T. Ashton,David B. Johnston,Richard L. Tolman	324
13	A DNA polymerase from embryos of Drosophila melanogaster. Purification and properties. 1975 ·Journal of Biological Chemistry ·J D Karkas,Lola Margulies,Erwin Chargaff	20
14	Separation of B. subtilis DNA into complementary strands. 3. Direct analysis. 1968 ·Proceedings of the National Academy of Sciences ·Rivka Rudner,J D Karkas,Erwin Chargaff	139
15	Separation of B. subtilis DNA into complementary strands, I. Biological properties. 1968 ·Proceedings of the National Academy of Sciences ·Rivka Rudner,J D Karkas,Erwin Chargaff	52
16	Seapration of B. subtilis DNA into complementary strands. II. Template functions and composition as determined by transcription with RNA polymerase. 1968 ·Proceedings of the National Academy of Sciences ·J D Karkas,Rivka Rudner,Erwin Chargaff	52
17	Template functions in the enzymic formation of polyribonucleotides. IV. Denatured DNA as template. 1967 ·Proceedings of the National Academy of Sciences ·J D Karkas,Erwin Chargaff	7
18	Template functions in the enzymic formation of polyribonucleotides, II. Metaphase chromosomes as templates in the enzymic synthesis of ribonucleic acid. 1966 ·Proceedings of the National Academy of Sciences ·H J Lin,J D Karkas,Erwin Chargaff	9
19	Template functions in the enzymic formation of polyribonucleotides, I. Integrity of the DNA template. 1966 ·Proceedings of the National Academy of Sciences ·J D Karkas,Erwin Chargaff	16
20	Template functions in the enzymic formation of polyribonucleotides. 3. Apurinic acid as template. 1966 ·Proceedings of the National Academy of Sciences ·J D Karkas,Erwin Chargaff	10

About J D Karkas

J D Karkas is a scholar working on Biotechnology, Epidemiology and Virology, having authored 21 papers that have together received 1.1k indexed citations. Recurring topics across this work include Herpesvirus Infections and Treatments (6 papers), Cytomegalovirus and herpesvirus research (6 papers) and Metal complexes synthesis and properties (3 papers). The work is most often cited by research in Epidemiology (327 citations), Molecular Biology (636 citations) and Biotechnology (75 citations). J D Karkas has collaborated with scholars based in United States, Canada and Australia. Frequent co-authors include Erwin Chargaff, Rivka Rudner, Richard L. Tolman, Richard Liou, John I. Germershausen, Anjalie Field, Wallace T. Ashton, Helen C. Perry, David B. Johnston and Corrille M. DeWitt. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Biochemical and Biophysical Research Communications.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact